HomeNewsBusinessMoneycontrol ResearchAnother great quarter for Dr Reddy’s, but is it sustainable?

Another great quarter for Dr Reddy’s, but is it sustainable?

EMs are expected to remain the chief driver of top-line growth, driven by chronic therapies and biosimilars

Anubhav Sahu

January 27, 2023 / 10:02 IST

Another great quarter for Dr Reddy’s, but is it sustainable?

As competition with peers heats up and exclusivity with regard to few strengths would end in Q1FY24, we believe sales traction from g-Revlimid will moderate over the next few quarters

Watch Webinar

PRO Panorama

Moneycontrol Pro Panorama | Gold or Bitcoin: Which has a more compelling story?

Oct 10, 2025 / 03:07 PM IST

In Moneycontrol Pro Panorama October 10 edition: Why World Bank wants South Asia to cut tariffs, market move a breakout, breakdown...
Read Now
PRO Weekender

Moneycontrol Pro Weekender | India Earnings Season: Why Q2 doesn't matter, and the rusty nail of US tariffs

Oct 11, 2025 / 10:00 AM IST

The September quarter results may be largely irrelevant--sandwiched between export front-loading before Trump's tariff deadline an...
Read Now

Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

Ad free Experience

Seamless navigation, faster responses.
Expert Perspective

Explore 230+ exclusive editorials every month
+

Uncover Insights from World-Renowned Experts and Journalists
Actionable Insights

40+ weekly investment ideas + 3 to 4 daily technical calls
Virtual Events

Exclusive Live Webinars for Expert Trading & Investment Strategies!
Newsletters

Stay ahead with daily and weekly insights

View Offers

Unlock exclusive discounts

Disclosure & Disclaimer

This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More